Aspire Biopharma Holdings (ASBP) Q4 2025 Annual Earnings

Screener

Reported March 30, 2026

Revenue$4.3K

EPS-$1.33

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$63.1K Q1 2026$28.4K

Q4 2025$4.3K

Diluted EPS

Q2 2026-$1.00 Q1 2026-$20.57

Q4 2025-$1.33

Q3 2025-$1.60 Q2 2025-$0.04 Q1 2025-$0.42

FAQ

When did Aspire Biopharma Holdings report Q4 2025 earnings?: Aspire Biopharma Holdings (ASBP) reported Q4 2025 earnings on March 30, 2026.
What were Aspire Biopharma Holdings's Q4 2025 revenue and EPS?: Aspire Biopharma Holdings reported revenue of $4.3K and eps of $-1.33 for Q4 2025.
How did Aspire Biopharma Holdings's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, eps declined 391.1% from $-0.27.
Where can I find Aspire Biopharma Holdings's Q4 2025 SEC filings?: You can read the 10-K periodic report (0001493152-26-013682) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Aspire Biopharma Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk